NLRP6 and infectious otitis media: In mouse models of colitis‐associated cancer induced by treatment with AOM or DSS, NLRP6‐deficient mice developed significantly more and larger tumours than did wild‐type mice.24 In that study, the authors addressed the protective role of NLRP6 in tumour development for the first time.